Dar Al Dawa Development & Investment

Dar Al Dawa Development & Investment is a prominent pharmaceutical company based in Jordan, established in 1975. It specializes in the development, manufacturing, and marketing of high-quality generic pharmaceuticals across a broad spectrum of therapeutic classes, including cardiovascular, anti-infective, and central nervous system treatments. The company operates state-of-the-art manufacturing facilities that comply with international Good Manufacturing Practice (GMP) standards, serving markets across the Middle East, North Africa, and Europe. Dar Al Dawa is recognized for its commitment to providing affordable healthcare and its extensive portfolio of over 200 products. As a publicly traded entity on the Amman Stock Exchange, it remains a cornerstone of the regional healthcare industry.